Partially offsetting this are declines in cardiovascular drug Xarelto due to loss of exclusivity events across various territories ... falling to close to EUR 20 billion by 2028. Bayer's steady cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback